Cargando…
Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia
Targeting of cancer stem cells is believed to be essential for curative therapy of cancers, but supporting evidence is limited. Few selective target genes in cancer stem cells have been identified. Here we identify the arachidonate 5-lipoxygenase (5-LO) gene (Alox5) as a critical regulator for leuke...
Autores principales: | Chen, Yaoyu, Hu, Yiguo, Zhang, Haojian, Peng, Cong, Li, Shaoguang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887745/ https://www.ncbi.nlm.nih.gov/pubmed/19503090 http://dx.doi.org/10.1038/ng.389 |
Ejemplares similares
-
Molecular signatures of chronic myeloid leukemia stem cells
por: Chen, Yaoyu, et al.
Publicado: (2013) -
The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells
por: Zhang, Haojian, et al.
Publicado: (2012) -
Inhibitory Effects of Omacetaxine on Leukemic Stem Cells and BCR-ABL-Induced Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Mice
por: Chen, Yaoyu, et al.
Publicado: (2009) -
Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia
por: Chen, Yaoyu, et al.
Publicado: (2014) -
Functional Ramifications for the Loss of P-Selectin Expression on Hematopoietic and Leukemic Stem Cells
por: Sullivan, Con, et al.
Publicado: (2011)